a:2:{s:4:"TEXT";s:40:"Primary cardiac tumors: current approach";s:4:"TYPE";s:4:"HTML";}
Authors:
Company:
Bakoulev National Medical Research Center for Cardiovascular Surgery of Ministry of Health of the Russian Federation, Rublevskoe
shosse, 135, Moscow, 121552, Russian Federation
E-mail: Сведения доступны для зарегистрированных пользователей.
UDC: 616.12-006
Link: Clinical Physiology of Blood Circulaiton. 2017; 1 (3-4): 123-132
Keywords:
primary cardiac tumors
multidisciplinary approach
neoadjuvant and adjuvant therapy
resection
cryoablation
Abstract
Since 1952 when H.T. Bahnson and E.V. Newman performed the first successful excision of a cardiac tumor and then in 1954 a first successful atrial myxoma excision using a heart lung bypass by C. Crawfoord, surgery on primary cardiac tumors in the last six decades has improved tremendously due to increasing knowledge and diagnostic capabilities. Despite this, management of cardiac tumors remain a challenge. At present, there is no clear management breakthroughs and standardised treatment for primary cardiac tumors especially malignant ones. Many treatment strategies have been suggested in different institutions worldwide, but tend to be limited in data and evidence because of rarity of the disease. This paper reviews primary cardiac tumors, management strategies and midterm/long term outcomes. In recent literature emphasis is on multimodality and multidisciplinary approach in treatment strategies, which include a multiple-technique approach to the imaging of cardiac tumors, consisting of cardiac 3D transthoracic echocardiography, computed tomography, cardiac magnetic resonance imaging, and positron emission tomography, aggressive total surgical resection and neoadjuvant or/and adjuvant therapy which has shown to improve survival in patients with malignant primary cardiac tumors.References
1. Myers J.L., Mehta S.M. Congenital Heart SurgeryNomenclature and Database Project: Cardiac Tumors. Ann.
Thorac. Surg. 2000; 69: S358–68.
2. Бокерия Л.А., Бокерия О.Л., Донаканян С.А., Биниашви-
ли М.Б., Петросян А.Д. Случай успешного удаления ги-
гантской опухоли левого предсердия, с последующей им-
плантацией электрокардиостимулятора. Саратовский
научно-медицинский журнал. 2013; 9 (2): 321–4.
3. Cresti A., Chiavarelli M., Glauber M., Tanganelli P., Scalese M., Cesareo
F. et al. Incidence rate of primary cardiac tumors: a 14-year
population study. J. Cardiovasc. Med. (Hagerstown). 2016;
17 (1): 37–43. DOI: 10.2459/JCM.0000000000000059.
4. Thiene G., Basso C., Rizzo S., Gerosa G., Stellin G., Valente M.
(Eds.). Cardiac Tumor Pathology: Current Clinical Pathology.
NY: Springer Science+Business Media; 2013: 23–30. DOI:
10.1007/978-1-62703-143-1_2.
5. Burke A., Virmani R. Tumors of the heart and great vessels. In:
Atlas of tumor pathology. 3rd Series. Fascicle 16. Washington,
DC: Armed Forces Institute of Pathology; 1996.
6. Малашенков А.И., Кавсадзе В.Э. Хирургия опухолей серд-
ца. Учебно-методическое пособие для врачей. Под ред. ака-
демика РАМН Л.А Бокерия. М.: НЦССХ им А.Н. Бакулева;
2004: 17–19.
7. Li H., Xu D., Chen Z., Ding W., Hong T., Chen H. et al.
Prognostic analysis for survival after resections of localized primary
cardiac sarcomas: a single-institution experience. Ann.
Thorac. Surg. 2014; 97 (4): 1379–86.
8. Reynen K., Ko¨ckeritz U., Strasser R.H. Metastases to the heart.
Ann. Oncol. 2004; 15 (3): 375–81.
9. Motomatsu Y., Oishi Y., Matsunaga S., Onitsuka H., Yamamoto
H., Zaitsu E. et al. Primary cardiac t-cell lymphoma localized
in the mitral valve. Ann. Thorac. Surg. 2016; 101 (6): 2363–5.
DOI: 10.1016/j.athoracsur.2015.08.091.
10. Bjessmo S., Ivert T. Cardiac myxoma: 40 years' experience in
63 patients. Ann. Thorac. Surg. 1997; 63: 697–700.
11. Jun Amano, Jun Nakayama, Yasuo Yoshimura, Uichi Ikeda.
Clinical classification of cardiovascular tumors and tumor-like
lesions, and its incidences. Gen. Thorac. Cardiovasc. Surg.
2013; 61 (8): 435–47. DOI: 10.1007/s11748-013-0214-8.
12. Ostrowski S., Marcinkiewicz A., Ko_mider A., Jaszewski R.
Sarcomas of the heart as a difficult interdisciplinary problem.
Arch. Med. Sci. 2014; 10 (1): 135–48.
13. Burke A., Tavora F. The 2015 WHO Classification of Tumors of
the Heart and Pericardium. J. Thorac. Oncol. 2016; 11 (4):
441–52. DOI: 10.1016/j.jtho.2015.11.009.
14. Rice D.C., Reardon M.J. Left heart sarcomas. Methodist.
DeBakey Cardiovasc. J. 2010; 6 (3): 50–3.
15. Ricardo Ribeiro Dias, Fa′bio Fernandes, Fe′lix Jose′ Alvarez
Ramires, Charles Mady, Cícero Piva Albuquerque, Fa′bio
Biscegli Jatene. Mortality and embolic potential of cardiac
tumors. Arq. Bras. Cardiol. 2014; 103 (1): 13–8. DOI:
10.5935/abc.20140096.
16. Vyas K.S., Whitaker J., Saha S.P. Surgical management of
benign tumors of the heart: a rare but important pathology. J.
Surg. Open Access. 2016; 2 (2). DOI: http://dx.doi.org/
10.16966/2470-0991.115.
17. Rahmanian P.B., Castillo J.G., Sanz J., Adams D.H., Filsoufi F.
Cardiac myxoma: preoperative diagnosis using a multimodal
imaging approach and surgical outcome in a large contemporary
series. Interact. Cardiovasc. Thorac. Surg. 2007; 6:
479–83. DOI: 10.1510/icvts.2007.154096.
18. Habertheuer A., Laufer G., Wiedemann D., Andreas M.,
Ehrlich M., Rath C., Kocher A. Primary cardiac tumors on the
verge of oblivion: A European experience over 15 years.
J. Cardiothorac. Surg. 2015; 10: 56.
19. Burke A.P., Veinot J.P., Loire R., Virmani R., Tazelaar H.,
Kamiya H. et al. Tumors of the heart. In: Travis W.D.,
Brambilla E., Mu¨ller-Hermelink H.K., Harris C.C. (Eds.).
Tumours of the lung, pleura, thymus and heart. Lyon: JARC
Press; 2004: 260–265.
20. Basso C., Rizzo S., Valente M., Thiene G. Cardiac masses and
tumours. Heart. 2016; 102 (5): 1230–45. DOI:10.1136/
heartjnl-2014-306364.
21. Abu Saleh W.K., Al Jabbari O., Ramlawi B., Reardon M.J.
Cardiac Papillary Fibroelastoma: Single-Institution Experience
with 14 Surgical Patients. Tex. Heart Inst. J. 2016; 43 (2):
148–51. DOI: 10.14503/THIJ-14-4889.
22. Skopin I.I., Serov R.A., Makushin A.A, Sazonenkov M.A.
Primary rhabdomyosarcoma of the right atrium. Interact.
Cardiovasc. Thorac. Surg. 2003; 2: 316–8.
23. Oliveira G.H., Sadeer G. Al-Kindi, Hoimes Ch., Park S.J.
Characteristics and survival of malignant cardiac tumors:
a 40-year analysis of over 500 patients. Circulation. 2015;
132: 2395–402. DOI: 10.1161/CIRCULATIONAHA.115.
016418.
24. Travis W.D, Brambilla E., Burke A.P., Marx A., Nicholson A.G.
WHO classification of tumours of the lung, pleura, thymus and
heart. 4th ed. Lyon: International Agency for Research on
Cancer; 2015.
25. Hamidi M., Moody J.S., Weigel T.L., MD, Kozak K.R. Primary
cardiac sarcoma. Ann. Thorac. Surg. 2010; 90: 176–81.
26. Бокерия Л.А., Голухова Е.З., Машина Т.В., Кубова М.Ч. Лей-
омиосаркома левого предсердия. Креативная кардиоло-
гия. 2014; 3: 56–63.
27. Furukawa N., Gummert J., Bo¨rgermann J. Complete resection
of undifferentiated cardiac sarcoma and reconstruction of the
atria and the superior vena cava: case report. J. Cardiothorac.
Surg. 2012; 7: 96.
28. Ramlawi B., Leja M.J., Abu Saleh W.K., Al Jabbari O.,
Benjamin R., Ravi V. et al. Surgical treatment of primary cardiac
sarcomas: review of a single-institution experience. Ann.
Thorac. Surg. 2016; 101: 698–702. DOI: 10.1016/j.athoracsur.
2015.07.087.
29. Shapira O.M., Korach A., Izhar U., Koler T., Wald O., Ayman M.
et al. Radical multidisciplinary approach to primary cardiac sarcomas.
Eur. J. Cardio-Thorac. Surg. 2013; 44 (2): 330–336.
30. Abu Saleh W.K., Ramlawi B., Shapira O.M., Al Jabbari O.,
Ravi V., Benjamin R., Reardon M.J. Improved outcomes with
the evolution of a neoadjuvant chemotherapy approach to right
heart sarcoma. Ann. Thorac. Surg. 2017; 104 (1): 90–6. DOI:
10.1016/j.athoracsur.2016.10.054
31. Andrushchuk U., Ostrovsky Y., Zharkov V., Amelchanka S.,
Krutau V., Yudina O. et al. for massive malignant tumors of the
left atrium. Kardiochir. Torakochirurgia Pol. 2016; 13 (3):
229–35. DOI: 10.5114/kitp.2016.62610.
32. Saraiva J., Antunes P.E., Carvalhob L., Antunes M.J. Primary
malignant cardiac tumors: Surgical results. Rev. Port. Cardiol.
2016; 35 (4): 199–204.
33. Liang Yin, Dengke He, Hua Shen, Xinyu Ling, Wei Li, Qian Xue,
Zhinong Wang. Surgical treatment of cardiac tumors: a 5-year
experience from a single cardiac center. J. Thorac. Dis. 2016; 8
(5): 911–9. DOI: 10.21037/jtd.2016.03.87.
34. Paraskevaidis I.A., Michalakeas C.A., Papadopoulos C.H.,
Anastasiou-Nana M. Cardiac Tumors. Review Article. ISRN
Oncology. 2011; 2011: 5. Article ID 208929.
http://dx.doi.org/10.5402/2011/208929.
35. Jeong D., Patel A., Francois C.J., Gage K.L., Fradley M.G.
Cardiac magnetic resonance imaging in oncology. Cancer
Control. 2017; 24 (2); 147–60.
36. Toshiaki Isogai, Hideo Yasunaga, Hiroki Matsui, Hiroyuki Tanaka,
Motoyuki Hisagi, Kiyohide Fushimi. Factors affecting in-hospital
mortality and likelihood of undergoing surgical resection in
patients with primary cardiac tumors. J. Cardiol. 2017; 69 (1):
287–92. Http://dx.doi.org/10.1016/j.jjcc.2016.05.008.
37. Bruckner B.A., Rodriguez L.E., Bunge R., Motomura T.,
Estep J.D., Loebe M., Reardon M.J. Large cardiac tumor managed
with resection and two ventricular assist devices. Ann.
Thorac. Surg. 2014; 97: 321–4.
38. Hoffmeier A., Sindermann J.R., Scheld H.H., Martens S.
Cardiac tumors – diagnosis and surgical treatment. Dtsch.
Arztebl. Int. 2014; 111 (12): 205–11. DOI: 10.3238/arztebl.
2014.0205.
39. Kremer J., Farag M., Arif R., Brcic A., Sabashnikov A.,
Schmack B. et al. Total artificial heart implantation after undifferentiated
high-grade sarcoma excision. Med. Sci. Monit.
Basic. Res. 2016; 22: 128–31.
40. Ramlawi B., Odeaa Al-jabbari, Blau L.N., Davies M.G.,
Bruckner B.A., Blackmon S.H. et al. Autotransplantation for
the resection of complex left heart tumors. Ann. Thorac. Surg.
2014; 98: 863–8.
41. Reardon M.J., Malaisrie S.C., Walkes J.-C., Vaporciyan A.A.,
Rice D.C., Smythe W.R. et al. Cardiac Autotransplantation for
Primary Cardiac Tumors. Ann. Thorac. Surg. 2006; 82:
645–50.
42. Yu¨ksel A., Saba D., Veliogˇlu Y., Ener S., Özkan H. Biatrial
approach provides better outcomes in the surgical treatment of
cardiac myxomas. Braz. J. Cardiovasc. Surg. 2016; 31 (4):
309–17. DOI: 10.5935/1678-9741.20160066.
43. Shah I.K., Dearani J.A., Daly R.C., Suri R.M., Park S.J.,
Joyce L.D. et al. Cardiac myxomas: a 50-year experience with
resection and analysis of risk factors for recurrence. Ann.
Thorac. Surg. 2015; 100: 495–500.
44. Marvasti M.A., Obeid A.I., Potts J.L., Parker F.B. Approach in
the management or atrial myxoma with long-term follow-up.
Ann. Thorac. Surg. 1984; 38 (1): 53–8. DOI:
http://dx.doi.org/ 10.1016/S0003-4975(10)62186-8.
45. Hussain S.T., Sepulveda E., Desai M.Y., Pettersson G.B.,
Gillinov A.M. Successful re-repeat resection of primary left atrial
sarcoma after previous tumor resection and cardiac autotransplant
procedures. Ann Thorac Surg. 2016; 102 (3):
e227–e228. DOI: 10.1016/j.athoracsur.2016.01.024.
46. Hermanek P., Wittekind C. The pathologist and the residual
tumor (R) classification. Path. Res. Pract. 1994; 190: 115–23.
DOI: 10.1016/S0344-0338(11)80700-4.
47. Майтесян Ш.А., Мироненко В.А., Макаренко В.Н., Се-
ров Р.А., Мутема Ч.А., Александрова С.А. и др. Двадцать че-
тыре месяца после субтотальной резекции и криодеструк-
ции обструктивной фибросаркомы в правом желудочке.
Бюллетень НЦССХ им А.Н Бакулева. Сердечно-сосудис-
тые заболевания. 2017; 3 (18): 170.
48. Padmanabhan S., Sy R.W., McGuire M.A. Cryoablation for atrial
fibrillation in 2017: what have we learned? Heart, Lung and
Circulation. 2017; 26 (9): 950–9. http://dx.doi.org/10.1016/
j.hlc.2017.05.115.
About Authors
- Mutema Alfred Chileshe, Postgraduate, Cardiovascular Surgeon, e-mail: chileshemutema@gmail.com, 0000-0002-9132-737X;
- Mironenko Vladimir Alexandrovich, Dr. Med. Sc., Head of Department, 0000-0003-1533-6212